MIDSHIPS: Multicentre Intervention Designed for Self-Harm using Interpersonal Problem-Solving: protocol for a randomised controlled feasibility study

Trials

Amanda Farrin¹  Sandy Tubeuf²  David Protheroe³  Louise Pembroke²  Katie Martin³  Allan House²  Simon Hatcher⁴  Liz Graham¹  Kayleigh Burton¹  Paul Blenkiron³  David Owens²  Michelle Collinson¹ 

[1] Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds LS2 9JT, UK;Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9JT, UK;Leeds and York Partnership NHS Foundation Trust, 2150 Century Way, Thorpe Park, Leeds LS15 8ZB, UK;Department of Psychiatry, University of Ottawa, 5457-1145 Carling Avenue, Ottawa, Ontario K1Z 7 K4, Canada

关键词: Self-injury;    Self-poisoning;    Suicide;    Problem-solving therapy;    Self-harm;   

Others  :  806392
DOI  :  10.1186/1745-6215-15-163

 received in 2014-03-06, accepted in 2014-04-22,  发布年份 2014

【 摘 要 】

Background

Around 150,000 people each year attend hospitals in England due to self-harm, many of them more than once. Over 5,000 people die by suicide each year in the UK, a quarter of them having attended hospital in the previous year because of self-harm. Self-harm is a major identifiable risk factor for suicide. People receive variable care at hospital; many are not assessed for their psychological needs and little psychological therapy is offered. Despite its frequent occurrence, we have no clear research evidence about how to reduce the repetition of self-harm. Some people who have self-harmed show less active ways of solving problems, and brief problem-solving therapies are considered the most promising psychological treatments.

Methods/Design

This is a pragmatic, individually randomised, controlled, feasibility study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual alone, for adults attending a general hospital following self-harm. A total of 60 participants will be randomised equally between the treatment arms, which will be balanced with respect to the type of most recent self-harm event, number of previous self-harm events, gender and age. Feasibility objectives are as follows: a) To establish and field test procedures for implementing the problem-solving intervention; b) To determine the feasibility and best method of participant recruitment and follow up; c) To assess therapeutic delivery; d) To assess the feasibility of obtaining the definitive trial’s primary and secondary outcomes; e) To assess the perceived burden and acceptability of obtaining the trial’s self-reported outcome data; f) To inform the sample size calculation for the definitive trial.

Discussion

The results of this feasibility study will be used to determine the appropriateness of proceeding to a definitive trial and will allow us to design an achievable trial of interpersonal problem-solving therapy for adults who self-harm.

Trial registration

Current Controlled Trials (ISRCTN54036115)

【 授权许可】

   
2014 Collinson et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Hawton K, Zahl D, Weatherall R: Suicide following deliberate self-harm: long-term follow-up of patients who presented to a general hospital. Br J Psychiatry 2003, 182:537-542.
• [2]Bergen H, Hawton K, Waters K, Cooper J, Kapur N: Epidemiology and trends in non-fatal self-harm in three centres in England, 2000 to 2007. Br J Psychiatry 2010, 197:493-498.
• [3]Hawton K, Bergen H, Casey D, Simkin S, Palmer B, Cooper J, Kapur N, Horrocks J, House A, Lilley R, Noble R, Owens D: Self-harm in England: a tale of three cities. Soc Psychiatry Psychiatr Epidemiol 2007, 42:513-521.
• [4]Comtois K, Russo J, Snowden M, Srebnik D, Ries R, Roy-Byrne P: Factors associated with high use of public mental health services by persons with borderline personality disorder. Psychiatr Serv 2003, 54:1149-1154.
• [5]Owens D, Horrocks J, House A: Fatal and non-fatal repetition of self-harm: a systematic review. Br J Psychiatry 2002, 181:193-199.
• [6]Cooper J, Kapur N, Webb R, Lawlor M, Guthrie E, Mackway-Jones K, Appleby L: Suicide after deliberate self-harm: a 4 year cohort study. Am J Psychiatry 2005, 162:297-303.
• [7]Owens D, Wood C, Greenwood D, Hughes T, Dennis M: Mortality and suicide after non-fatal self-poisoning: a 16-year outcome study of patients attending accident and emergency. Br J Psychiatry 2005, 187:470-475.
• [8]Owens D, House A: General hospital services for deliberate self-harm. J Roy Coll Phys Lond 1994, 28:370-371.
• [9]Hawton K, Harriss L, Zahl D: Death from all causes in a long-term follow-up study of 11 583 deliberate self-harm patients. Psychol Med 2006, 36:397-405.
• [10]Carter G, Reith DM, Whyte IM, McPherson M: Non-suicidal deaths following hospital-treated self-poisoning. Aust NZ J Psychiat 2005, 39:101-107.
• [11]Karasouli E, Owens D, Abbott RL, Hurst KM, Dennis M: All-cause mortality after non-fatal self-poisoning: a cohort study. Soc Psychiatry Psychiatr Epidemiol 2011, 46:455-462.
• [12]Milnes D, Owens D, Blenkiron P: Problems reported by self-harm patients: perception, hopelessness and suicidal intent. J Psychosom Res 2002, 53:819-822.
• [13]Gunnell D, Bennewith O, Peters TJ, House A, Hawton K: The epidemiology and management of self-harm amongst adults in England. J Public Health 2005, 27:67-73.
• [14]Hawton K, Townsend E, Arensman E, Gunnell D, Hazell P, House A, van Heeringen K: Psychosocial and pharmacological treatments for deliberate self-harm. Cochrane DB Syst Rev 1999., (Issue 4) DOI: 10.1002/14651858.CD001764
• [15]Townsend E, Hawton K, Altman DG, Arensman E, Gunnell D, Hazell P, House A, van Heeringen K: The efficacy of problem-solving treatments after deliberate self-harm: meta-analysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems. Psychol Med 2001, 31:979-988.
• [16]U.S. Preventive Services Task Force: Screening for suicide risk: recommendation and rationale. Ann Intern Med 2004, 140:820-821.
• [17]National Institute for Clinical Excellence: Self harm: the short term physical and psychological management and secondary prevention of self-harm in primary and secondary care (CG16). London: NICE; 2004.
• [18]Royal College of Psychiatrists: Self-harm, suicide and risk: helping people who self-harm (CR158). London: Royal College of Psychiatrists; 2010.
• [19]Tyrer P, Thompson S, Schmidt U, Jones V, Knapp M, Davidson K, Catalan J, Airlie J, Baxter S, Byford S, Byrne G, Cameron S, Caplan R, Cooper S, Ferguson B, Freeman C, Frost S, Godley J, Greenshields J, Henderson J, Holden N, Keech P, Kim L, Logan K, Manley C, MacLeod A, Murphy R, Patience L, Ramsay L, De Munroz S, et al.: Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med 2003, 33:969-976.
• [20]Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE, Beck AT: Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA 2005, 294:563-570.
• [21]Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, Korslund KE, Tutek DA, Reynolds SK, Lindenboim N: Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006, 63:757-766.
• [22]Hatcher S, Sharon C, Parag V, Collins N: Problem-solving therapy for people who present to hospital with self-harm: Zelen randomised controlled trial. Br J Psychiatry 2011, 199:310-316.
• [23]National Institute for Health and Care Excellence: The NICE Guideline on Longer-term Management in adults, children and young people (CG133). London: NICE; 2012.
• [24]Ware JE, The SCD, MOS: 36-item Short-Form Health Survey (SF-36). Med Care 1992, 30:473-481.
• [25]Lancaster GA, Dodd S, Williamson PR: Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004, 10:307-312.